Pain Associated With Endometriosis

ClinicalTrials.gov ID: NCT00758953

Public ClinicalTrials.gov record NCT00758953. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT00758953
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Lumara Health, Inc.; Industry
Enrollment: 66 participants

Conditions and interventions

Conditions

Endometriosis

Interventions

Danazol Once Weekly Drug
Danazol Twice Weekly Drug
Placebo Once Weekly Drug
Placebo Twice Weekly Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 50 Years
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 31, 2007
Primary completion: Dec 31, 2008
Completion: Dec 31, 2008
Last update posted: Mar 5, 2012

2007 – 2009

United States locations

U.S. sites: 38
U.S. states: 19
U.S. cities: 33

Facility	City	State	ZIP	Site status
Not listed	Chandler	Arizona	85225	—
Not listed	Phoenix	Arizona	85015	—
Not listed	Phoenix	Arizona	85032	—
Not listed	Little Rock	Arkansas	72205	—
Not listed	Carmichael	California	95608	—
Not listed	San Diego	California	92121	—
Not listed	San Diego	California	92123	—
Not listed	San Diego	California	92130	—
Not listed	Denver	Colorado	80206	—
Not listed	Britain	Connecticut	06050	—
Not listed	West Hartford	Connecticut	06117	—
Not listed	Aventura	Florida	33180	—
Not listed	Boynton Beach	Florida	33437	—
Not listed	Clearwater	Florida	33759	—
Not listed	Hudson	Florida	34667	—
Not listed	Tampa	Florida	33607	—
Not listed	Alpharetta	Georgia	30005	—
Not listed	Atlanta	Georgia	30342	—
Not listed	Decatur	Georgia	30034	—
Not listed	Boise	Idaho	83702	—
Not listed	Boise	Idaho	83712	—
Not listed	Champaign	Illinois	61820	—
Not listed	Baton Rouge	Louisiana	70808	—
Not listed	Chesterfield	Missouri	63017	—
Not listed	Moorestown	New Jersey	08057	—
Not listed	Winston-Salem	North Carolina	27103	—
Not listed	Bismarck	North Dakota	58501	—
Not listed	Fargo	North Dakota	58104	—
Not listed	Cleveland	Ohio	44122	—
Not listed	Columbus	Ohio	43231	—
Not listed	Abington	Pennsylvania	19001	—
Not listed	West Chester	Pennsylvania	19380	—
Not listed	Jackson	Tennessee	38305	—
Not listed	Memphis	Tennessee	38119	—
Not listed	Memphis	Tennessee	38120	—
Not listed	Nashville	Tennessee	37203	—
Not listed	Irving	Texas	75061	—
Not listed	Salt Lake City	Utah	84107	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00758953, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 5, 2012 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00758953 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →